Kiniksa Pharmaceuticals International Plc (KNSA)
77.09
-0.82
(-1.05%)
USD |
NASDAQ |
Sep 08, 16:00
80.00
+2.91
(+3.77%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Assets (Quarterly) : 896.11M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 896.11M |
| March 31, 2026 | 825.28M |
| December 31, 2025 | 763.63M |
| September 30, 2025 | 712.33M |
| June 30, 2025 | 661.15M |
| March 31, 2025 | 599.33M |
| December 31, 2024 | 580.55M |
| September 30, 2024 | 555.30M |
| June 30, 2024 | 542.43M |
| March 31, 2024 | 519.67M |
| December 31, 2023 | 526.32M |
| September 30, 2023 | 483.06M |
| June 30, 2023 | 484.33M |
| March 31, 2023 | 442.86M |
| December 31, 2022 | 459.67M |
| September 30, 2022 | 459.95M |
| June 30, 2022 | 210.58M |
| March 31, 2022 | 230.96M |
| Date | Value |
|---|---|
| December 31, 2021 | 232.80M |
| September 30, 2021 | 252.86M |
| June 30, 2021 | 279.21M |
| March 31, 2021 | 311.16M |
| December 31, 2020 | 349.46M |
| September 30, 2020 | 384.41M |
| June 30, 2020 | 271.44M |
| March 31, 2020 | 226.11M |
| December 31, 2019 | 254.53M |
| September 30, 2019 | 281.80M |
| June 30, 2019 | 308.14M |
| March 31, 2019 | 346.16M |
| December 31, 2018 | 321.96M |
| September 30, 2018 | 347.10M |
| June 30, 2018 | 365.13M |
| March 31, 2018 | 224.78M |
| December 31, 2017 | 47.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 493.23M |
| Barinthus Biotherapeutics Plc | 81.89M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Immunocore Holdings Plc | 1.119B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 241.96M |
| Shareholders Equity (Quarterly) | 654.15M |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 3.904 |
| Net Debt Paydown Yield | 0.00% |